Synemin
Synemin is a protein that in humans is encoded by the SYNM gene. It is a type of intermediate filament (IF) protein, which are crucial components of the cellular cytoskeleton. Synemin is expressed in various types of muscle tissue, including cardiac muscle and skeletal muscle, and plays a key role in maintaining the structural integrity and proper functioning of these tissues.
Structure[edit]
Synemin is a large protein, with a molecular weight of approximately 150 kDa. It is composed of a central rod domain flanked by non-helical head and tail domains. The rod domain is responsible for the protein's ability to form homodimers and heterodimers with other IF proteins, while the head and tail domains are thought to mediate interactions with other cellular components.
Function[edit]
Synemin functions as a linking protein, connecting the desmin intermediate filament network to dystrophin at the sarcolemma. This connection is crucial for the mechanical stability and resilience of muscle cells. In addition to its structural role, synemin is also thought to participate in signal transduction processes, although the details of these functions are not yet fully understood.
Clinical significance[edit]
Mutations in the SYNM gene have been associated with a variety of muscle-related disorders, including dilated cardiomyopathy and limb-girdle muscular dystrophy. These conditions are characterized by progressive muscle weakness and wasting, and can be severely debilitating or even life-threatening.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
